Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITPR3 | Q14573 | 3/20 | 0.37 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.34 |
| ▸ | ITPR2 | Q14571 | 1/20 | 0.33 |
| ▸ | ITPR1 | Q14643 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.32 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.32 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL406797 | 1.00 | ITPR3 (0.37) | ITPR3BTN3A1ITPR2ITPR1FDPS | |
| SCHEMBL544344 | 1.00 | ITPR3 (0.37) | ITPR3BTN3A1ITPR2ITPR1FDPS | |
| SCHEMBL136588 | 1.00 | ITPR3 (0.37) | ITPR3BTN3A1ITPR2ITPR1FDPS | |
| SCHEMBL12475062 | 1.00 | ITPR3 (0.37) | ITPR3BTN3A1ITPR2ITPR1FDPS | |
| SCHEMBL23211993 | 0.98 | ITPR3 (0.36) | ITPR3BTN3A1ITPR2ITPR1FDPS | |
| SCHEMBL1983636 | 0.98 | ITPR3 (0.36) | ITPR3BTN3A1ITPR2ITPR1FDPS | |
| SCHEMBL5014239 | 0.98 | ITPR3 (0.36) | ITPR3BTN3A1ITPR2ITPR1FDPS | |
| SCHEMBL29027317 | 0.98 | ITPR3 (0.36) | ITPR3BTN3A1ITPR2ITPR1FDPS | |
| SCHEMBL28639733 | 0.98 | ITPR3 (0.36) | ITPR3BTN3A1ITPR2ITPR1FDPS | |
| SCHEMBL5014242 | 0.98 | ITPR3 (0.36) | ITPR3BTN3A1ITPR2ITPR1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10824 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122029176-A | Containing a plurality of oligonucleotides modified oligonucleotides | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029177-A | Oligonucleotides containing multiple ligands and/or lipids | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12569555-B2 | Organically modified mineral micro-particles, methods of preparing the same and uses thereof | CRODA INTERNATIONAL PLC (GB) | 2026-03-10 | — | — | US | claimed |
| US-12564486-B2 | Devices and methods for treating an aneurysm | MERLIN MD PTE LTD. (SG) | 2026-03-03 | — | — | US | claimed |
| US-20260036593-A1 | DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS | UNIV CALIFORNIA (US) | 2026-02-05 | — | — | US | claimed |
| US-20250368948-A1 | PRODUCT, SYSTEM AND METHOD OF CELL CULTIVATION | BTL Healthcare Technologies a,s. | 2025-12-04 | — | — | US | claimed |
| EP-4011494-B1 | MICRO-NANOFLUIDIC CHIP, PREPARATION METHOD THEREFOR AND USE THEREOF | SHENZHEN INST ADV TECH (CN) | 2025-07-09 | — | — | EP | claimed |
| US-20250215028-A1 | SYNTHETIC GLYCEROPHOSPHOLIPIDS COMPRISING AT LEAST ONE REACTIVE FUNCTION, PROCESS FOR PREPARING SAME AND USES THEREOF IN DIFFERENT APPLICATIONS | UNIVERSITE DE ROUEN-NORMANDIE (FR) | 2025-07-03 | — | — | US | claimed |
| US-20250196140-A1 | MICRO- AND NANO-FLUIDIC CHIP, METHOD OF FABRICATING THE SAME, AND APPLICATIONS THEREOF | SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY (CN) | 2025-06-19 | — | — | US | claimed |
| CN-119824688-A | High-cohesive-force spandex with good unwinding property and preparation method thereof | 华峰化学股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| US-4735936-A | FREE RADICAL INHIBITION IN THE BODY | PERSTORP AB (SE) | 1988-04-05 | — | — | US | claimed |
| US-4735902-A | ORGANIC SUBSTRATES SUBJECT TO DEGRADATION BY OXIDATION OR FREE RADICALS | PERSTORP AB (SE) | 1988-04-05 | — | — | US | claimed |
| US-4734283-A | REMOVAL OF CADMIUM FROM BODY | PERSTORP AB (SE) | 1988-03-29 | — | — | US | claimed |
| EP-0252227-A2 | Use of inositol triphosphate in the treatment of metal intoxication | PERSTORP AB (SE) | 1988-01-13 | — | — | EP | claimed |
| US-4652449-A | Encapsulating biological active substances into erythrocytes | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1987-03-24 | — | — | US | claimed |
| EP-0101341-B1 | PROCESS AND DEVICE FOR THE ENCAPSULATION IN ERYTHROCYTES OF AT LEAST ONE BIOLOGICALLY ACTIVE SUBSTANCE, IN PARTICULAR HEMOGLOBIN ALLOSTERIC EFFECTORS, AND ERYTHROCYTES SO OBTAINED | Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1986-11-05 | — | — | EP | claimed |
| EP-0180581-A1 | DRUG PREPARATIONS OF REDUCED TOXICITY. | LIPOSOME CO INC (US) | 1986-05-14 | — | — | EP | claimed |
| EP-0179439-A1 | A pharmaceutical composition and a method for preparing same | Sirén, Matti (CH) | 1986-04-30 | — | — | EP | claimed |
| WO-1985005030-A1 | DRUG PREPARATIONS OF REDUCED TOXICITY | THE LIPOSOME COMPANY, INC. (US) | 1985-11-21 | — | — | WO | claimed |
| US-4321259-A | Controlled improvement of the O2 -release by intact erythrocytes | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1982-03-23 | — | — | US | claimed |